Back

Ten-year major clinical outcomes between first- and second-generation Drug-Eluting Stents in unstable angina patients underwent Percutaneous Coronary Intervention

28 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes Unstable Angina ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
The association between the hsCRP/BMI ratio and cardiovascular prognosis in CAD patients
Doctor J. Yang (Beijing, CN)
Abstract Slides
Presentation thumbnail
In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study
Mr Y. Wang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Association of inflammatory activation with acute stent thrombosis
Doctor K. Krychtiuk (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The influence of early post-STEMI inflammation on diastolic function: diagnostic and therapeutic implications
Doctor S. Filip (Iasi, RO)
Abstract Slides Video
Presentation thumbnail
Helicobacter pylori and pro-inflammatory protein biomarkers in myocardial infarction with and without obstructive coronary artery disease
Doctor J. Warme (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Ten-year major clinical outcomes between first- and second-generation drug-eluting stents in hypertensive patients underwent percutaneous coronary intervention
thumbnail
Congress Presentation
Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents
thumbnail
Congress Session
Registries, observational, and other studies on coronary disease including intervention and surgery

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources